Medicine composite for treating cytomegalovirus and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of cytomegalovirus and composition, which is applied in the direction of antiviral agents, pharmaceutical formulas, and medical preparations containing active ingredients, etc., can solve problems such as infection, and achieve the effect of short course of treatment, quick effect, and small side effects
Inactive Publication Date: 2011-03-30
肖华
View PDF0 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Western medicine for CMV infection, currently there is no particularly effective and safe anti-CMV drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0014] A pharmaceutical composition for treating cytomegalovirus is composed of the following components in the following weight ratios:
[0025] The preparation method is the same as in Example 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicine composite for treating cytomegalovirus, which comprises the following components in parts by weight: 62-95 parts of radix isatidis, 38-57 parts of honeysuckle, 5-20 parts of salvia miltiorrhiza, 16-35 parts of rhizoma atractylodis, 3-7 parts of alisma orientale and 22-43 parts of rhubarb. The taste of the radix isatidis is bitter and cold, and the radix isatidis enters the hepatic blood points and stomach blood points and is used for clearing away heat and toxic material and cooling blood; the taste of the honeysuckle is sweet and cold, the honeysuckle enters the lung channel and the stomach channel and is used for clearing away heat and toxic material; the taste of the rhizoma atractylodis is bitter and mild, the rhizoma atractylodis enters the spleen channel and the stomach channel and is used for invigorating the spleen, eliminating dampness, dispelling melancholy and avoiding dirty; the taste of the alisma orientale is sweet and cold, and the alisma orientale enters the kidney channel and the urinary bladder channel; and the taste of the rhubarb is bitter and cold, and the rhubarb enters the stomach channel, the spleen channel, the intestine channel, the liver channel and the pericardium channel. The medicine composite has the efficacy of purgating heat and bowels and is used for treating gastrointestinal real hot stagnancy, constipation, abdominal swelling, unpalpable abdominal pain, even high fever, coma and delirium like large chengqi decoction, or cold settling constipation due to Spleen Yang deficiency like spleen warming soup. The medicine has the characteristics of short treatment period, quick response, small side effect and the like.
Description
Technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a pharmaceutical composition for treating cytomegalovirus and a preparation method thereof. Background technique [0002] Cytomegalovirus infection is a systemic infectious disease caused by cytomegalovirus. After a pregnant woman is sick, it can be transmitted vertically to the fetus, causing intrauterine infection, causing severe symptoms and signs to the fetus, and even causing repeated miscarriage, premature delivery, stillbirth, Long-term sequelae such as congenital malformations, neonatal death, congenital stupidity, full-term infants, cerebral palsy, neonatal jaundice, mental retardation of infants, and delayed audiovisual and intellectual development after birth. Western medicine has no particularly effective and safe anti-CMV drugs for CMV infection. Summary of the invention [0003] The technical problem to be solved by the present invention is to provide a pharmaceutical co...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more